Lichen planus responding to efalizumab

Journal of the American Academy of Dermatology

Volumn 56, Issue 5 SUPPL., 2007, Pages

  Böhm, Markus ^a   Luger, Thomas A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LABORATORY TEST; LICHEN PLANUS; PATIENT REFERRAL; PRIORITY JOURNAL; SKIN BIOPSY; SKIN EXAMINATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIBODIES, MONOCLONAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LICHEN PLANUS; RECURRENCE; TREATMENT OUTCOME;

EID: 34047275267     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.10.957     Document Type: Article

References (9)

1. Xingyuan M., Wenyun Z., and Tianwen W. Leukocyte function-associated antigen-1: structure, function and application prospects. Protein Pept Lett 13 (2006) 397-400
2. Hogg N., Smith A., McDowall A., Giles K., Stanley P., Laschinger M., et al. How T cells use LFA-1 to attach and migrate. Immunol Lett 92 (2004) 51-54
3. Boehncke W.H., Kellner I., Konter U., and Sterry W. Differential expression of adhesion molecules on infiltrating cells in inflammatory dermatoses. J Am Acad Dermatol 26 (1992) 907-913
4. Ohta Y., Yonemoto K., Asai T., and Yaguchi A. Lichen planus annularis: an immunohistochemical study. Dermatology 19 (1992) 414-419
5. Cheng A., and Mann C. Oral erosive lichen planus treated with efalizumab. Arch Dermatol 142 (2006) 680-682
6. Scheinfeld N. Efalizumab: a review of events reported during clinical trials and side effects. Expert Opin Drug Saf 5 (2006) 197-209
7. Gaylor M.L., and Duvic M. Generalized pustular psoriasis following withdrawal of efalizumab. J Drugs Dermatol 3 (2004) 77-79
8. Lowes M.A., Turton J.A., Krueger J.G., and Barnetson R.S. Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series. BMC Dermatol 18 (2005) 1-6
9. Hamilton T.K. Clinical considerations of efalizumab therapy in patients with psoriasis. Semin Cutan Med Surg 24 (2005) 19-27